This agreement paves the way for research projects leading to meaningful impact for analysts using biomedical mass spectrometry (MS), validated by peer-reviewed publications, presentations at international conferences and an outreach education program, said Waters.
At the core of the collaborative agreement is the establishment of ‘The Waters Centre for BioMedical Mass Spectrometry’ at the University of Warwick. This center will offer scientists worldwide an accessible resource to enable the adoption of liquid chromatography/MS-based techniques in life science, added Waters.
Brian Smith, vice president of MS operations for the Waters division, said: “The University of Warwick is consistently ranked amongst the top research universities, with a historic track record in biological MS. However, this agreement is not based on reputation alone; it is based on a long-standing relationship with the university and professor James Scrivens in particular.
“Waters looks forward to taking this relationship to the next level through mutually beneficial research and an educational resource for life scientists adopting cutting edge MS-based research strategies.”